Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Improving Palliative Care Through Teamwork (IMPACTT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01990742
Recruitment Status : Completed
First Posted : November 21, 2013
Results First Posted : August 20, 2018
Last Update Posted : September 17, 2018
Sponsor:
Collaborator:
University of California, Irvine
Information provided by (Responsible Party):
Helena Temkin-Greener, University of Rochester

Brief Summary:

One in three Americans dies in a nursing home (NH) or in a hospital, shortly following transfer from a long-term care facility. The proportion of deaths occurring in NHs is projected to increase to 40% by 2020. Excellence in palliative and end-of-life (EOL) care must become a priority for these long-term care institutions. However, findings from NHs point to high incidence of pain and poor management of other symptoms and excessive reliance on hospitalizations, indicating inadequate EOL care quality. Expert opinion and research have suggested that poor EOL quality in NHs may be due to lack of palliative care training among staff and absence of EOL care protocols or guidelines, but research demonstrating that attention to these factors improves outcomes is absent. While dedicated care teams have been shown to improve outcomes for NH residents in need of specialized care, the impact of palliative care teams in improving resident outcomes has remained largely unstudied and untested. This will be the first randomized controlled trial to evaluate the impact of palliative care teams (PCTeam) on resident and staff outcomes, and care processes, in NHs.

Our objective is to demonstrate, using a randomized controlled trial design and a difference in difference analytic approach, that nursing home-based palliative care practice guidelines implemented through PCTeams will improve quality of care processes and outcomes for residents at the end of life.

We will adapt existing palliative care guidelines for EOL care, endorsed by the National Quality Forum (NQF), to the NH environment, deploy the adapted practice guidelines through a PCTeam model, and evaluate the effectiveness of this intervention on resident EOL outcomes and staff care processes and outcomes. The specific aims (SA) will address the following questions:

SA 1: Is PCTeam intervention effective in improving NH residents' EOL outcomes?

SA 2: Is PCTeam intervention effective in improving NH staff EOL care processes and outcomes?

In the context of these specific aims we will test the following hypotheses:

H1: Residents in NHs in the intervention arm, compared to the control, will achieve better EOL risk-adjusted outcomes and care processes with regard to:

  • Pain
  • Dyspnea
  • Depression
  • In-hospital deaths
  • Hospitalizations
  • Advance directives

H2: Direct care staff in NHs in the intervention arm, compared to the control, will achieve better EOL processes and outcomes measured by:

  • Assessment of EOL symptoms
  • Delivery of EOL care
  • Communication/coordination among providers
  • Communication with residents/families
  • Teamwork effectiveness
  • Staff satisfaction

H3: Family caregivers of decedent residents in the intervention NHs, compared to the control, will report receiving more patient and family centered care as measured by higher levels of satisfaction with:

  • Shared decision making between providers, the patient and the family
  • Care that is respectful of the patient wishes and dignity
  • Attention to the emotional and spiritual needs of the family.

    31 NHs in upstate New York have been recruited for the study (letters of support). Stakeholders include residents, family members, staff, policy makers, and others. The intervention will deploy theTeamSTEPPS, a team development model created by the Department of Defense and the Agency for Healthcare Research and Quality.


Condition or disease Intervention/treatment Phase
Palliative Care Behavioral: Palliative Care Team (PCTeam) Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 31 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Improving Palliative and End-of-Life Care in Nursing Homes
Actual Study Start Date : September 27, 2013
Actual Primary Completion Date : December 31, 2016
Actual Study Completion Date : April 1, 2017

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Palliative Care Team (PCTeam)
Palliative care teams will be established and will round with residents in the intervention homes.
Behavioral: Palliative Care Team (PCTeam)
Palliative care teams will be established and will round with residents in the intervention nursing homes.

No Intervention: Standard care
Usual care will be provided to residents in the control homes.



Primary Outcome Measures :
  1. Hospital Site of Death: Number of Decedents Cared for in an Enrolled and Assigned NH Facility, Who Were Transferred to a Hospital and Died in the Hospital During the Study Period [ Time Frame: 1 year ]
    This outcome measure, Hospital Site of Death, assesses whether death occured in a nursing home or in a hospital following transfer from the nursing home, among nursing home residents who were cared for in an enrolled facility.


Secondary Outcome Measures :
  1. Hospitalizations [ Time Frame: The last 90 days of life ]
    Number of hospitalizations in the last 90 days of life among decedents being cared for in the enrolled nursing homes


Other Outcome Measures:
  1. Number of Nursing Home Residents in Moderate-to-severe Pain [ Time Frame: up to 6 months prior to death ]
    Presence of moderate-to-severe pain within 6 months of the date of death, among decedents cared for in the enrolled nursing homes. The verbal descriptor pain scale, where the resident is asked to rate the intensity of their worst pain in the last five day was most often used, where 0 = no pain, 1 = mild pain , 2 = moderate pain, 3 = severe pain, 4 = very severe pain, and 9 = unable to answer. Lower numbers (0 or 1 ) on the scale are preferred, and a lower percentage of residents reporting pain intensity in the moderate or higher ranges is a better outcome. The verbal descriptor scale can be shared with elders verbally, as the name implies, or by asking the resident to point to a setting on a visual thermometer with these word choices.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • long-stay nursing home residents (>90 days)

Exclusion Criteria:

  • rehabilitative, post-acute residents (<90 days)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01990742


Locations
Layout table for location information
United States, New York
University of Rochester School of Medicine and Dentistry
Rochester, New York, United States, 14642
Sponsors and Collaborators
University of Rochester
University of California, Irvine
Investigators
Layout table for investigator information
Principal Investigator: Helena Temkin-Greener, PhD University of Rochester
Layout table for additonal information
Responsible Party: Helena Temkin-Greener, Professor, University of Rochester
ClinicalTrials.gov Identifier: NCT01990742    
Other Study ID Numbers: PCORI-641
First Posted: November 21, 2013    Key Record Dates
Results First Posted: August 20, 2018
Last Update Posted: September 17, 2018
Last Verified: August 2018